Related Experiment Video
Updated: Feb 26, 2026

06:26
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
976
Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients
Zhengtao Liu1,2,3, Shuping Que1, Adil Mardinoglu1,4
1Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
Hepatology (Baltimore, Md.)
|July 21, 2017
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
839
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
839
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
298
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
298
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244

